Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia
Cancer Chemotherapy and Pharmacology · 2024
DOI: 10.1007/s00280-024-04673-5 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von Takahiro Kobayashi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita City, Akita, Japan. takahiro@…. Hauptthemen laut MEDLINE: Azacitidine, Bridged Bicyclo Compounds, Heterocyclic, Leukemia, Myeloid, Acute, Neutropenia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Otsuka Pharmaceutical, Novartis Japan, Astellas Pharma.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita City, Akita, Japan. takahiro@med.akita-u.ac.jp.
- Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita City, Akita, Japan.
- Department of Pharmacokinetics, Akita University Graduate School of Medicine, Akita, Japan.
- Department of Pharmacy, Akita University Hospital, Akita, Japan.
- Department of Internal Medicine, Yuri Kumiai General Hospital, Yurihonjo, Japan.
- Department of Hematology, Akita City Hospital, Akita, Japan.
ORCID-Profile: Takahiro Kobayashi
Förderung
- Otsuka Pharmaceutical
- Novartis Japan
- Astellas Pharma
- Asahikasei Pharma Japan
- Ono Pharmaceutical
Zitieren
APA
Kobayashi, T., Sato, H., Miura, M., Fukushi, Y., Kuroki, W., Ito, F., Teshima, K., Watanabe, A., Fujishima, N., Kobayashi, I., Kameoka, Y., & Takahashi, N. (2024). Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04673-5
Vancouver
Kobayashi T, Sato H, Miura M, Fukushi Y, Kuroki W, Ito F, et al. Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04673-5
BibTeX
@article{Kobayashi2024,
author = {Kobayashi, Takahiro and Sato, Honami and Miura, Masatomo and Fukushi, Yayoi and Kuroki, Wataru and Ito, Fumiko and Teshima, Kazuaki and Watanabe, Atsushi and Fujishima, Naohito and Kobayashi, Isuzu and Kameoka, Yoshihiro and Takahashi, Naoto},
title = {Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2024},
doi = {10.1007/s00280-024-04673-5}
}
EUVIMED